Navigation Links
Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance
Date:9/18/2012

NEW YORK, Sept. 18, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance

http://www.reportlinker.com/p0969026/Innovations-in-Drug-Delivery---Broad-based-Proprietary-Technology-Platforms-to-Address-Delivery-Efficiency-and-Improve-Patient-Compliance.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

 

Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance

 

Summary

 

GBI Research, the leading business intelligence provider, has released its latest research, "Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance". The report provides an overview of the most exciting innovations in drug delivery technologies in major therapeutic areas – oncology, vaccines, diabetes, rheumatology and respiratory diseases. Each chapter highlights emerging companies with technologies that have the potential to transform drug delivery in that specific therapeutic area. The report also explores the current environment in healthcare and the pharmaceutical industry, and examines drivers and challenges for the use of innovative drug delivery technologies.

 

Drug delivery technologies provide commercial opportunities for pharmaceutical companies by improving the chances of success for a drug development project. They enable the formulation of a promising molecule that might have poor solubility or require selective delivery to a particular tissue, such as the brain. Similarly, drug delivery technologies may enable companies to differentiate products within crowded therapeutic areas, facilitate life cycle management for existing drugs, and reposition existing drugs – proprietary or generic – in new indications where the needs of the patient population are different or, again, where more targeted delivery is required. Products that are reformulated with novel drug delivery systems do not meet the traditional criteria for innovative products – in other words, products that include new active moieties. Nevertheless, GBI Research's analysis shows that the commercial success of existing products that rely on innovative drug delivery technologies is clear, and these products make significant positive changes for patients.

 

Scope

 

- Detailed analysis of the reasons for the industry to look closely at drug delivery technologies.

- Exploration of the environment in healthcare and the pharmaceutical industry that is driving companies to invest in drug delivery.

- Insight into collaborations between the largest pharmaceutical companies and smaller companies with innovative drug delivery technologies.

- Detailed insight into innovation in drug delivery in key therapeutic areas: oncology, vaccines, diabetes, rheumatology and respiratory diseases.

- Case studies of leading companies, their technologies and clinical data emerging from important drug development programs.

 

Reasons to buy

 

- Identify leading drug delivery companies.

- Learn about mergers, acquisitions and collaborations in drug delivery.

- Develop strategies and priorities for investing in drug delivery technologies.

- Understand the most important technologies and companies involved in developing new drug delivery technologies in key therapeutic areas.

- Explore the needs of patients in each therapeutic area and the ways in which drug delivery technologies can be used to meet these within drug development pipelines.

 

 

 

Table of Contents

1 Table of Contents

1 Table of Contents 5

1.1 List of Tables 7

1.2 List of Figures 7

2 Drug Delivery - An Overview 8

2.1 Introduction 8

2.2 The Drug Delivery Market 11

2.3 Market Trends Affecting Drug Delivery 12

2.3.1 Drivers within the Healthcare Environment 12

2.3.2 Pharmaceutical Industry 13

2.4 Leading Drug Delivery Companies 14

2.4.1 Pharmaceutical Company Drug Delivery Portfolios 16

2.4.2 Deal Making 16

3 Oncology 20

3.1 Introduction 20

3.2 PEGylation 23

3.3 Protein-Based Drug Delivery Systems 24

3.3.1 Albumin 24

3.3.2 Other Fusion Proteins 25

3.3.3 Hyaluronidase 25

3.4 Nanoparticles for Drug Delivery 26

3.4.1 Liposomes 26

3.4.2 Dendrimers 27

3.4.3 Polymer Delivery Systems 27

3.5 Tumor Targeting 28

3.5.1 Antibody-Drug Conjugates 29

3.6 Conclusions 30

4 Vaccines 31

4.1 DNA Vaccines 31

4.1.1 DNA Vaccines Delivered in Viral Vectors 32

4.1.2 Bacterial and Yeast-Based Antigen Delivery 34

4.2 'Naked' and Complexed DNA Vaccine Delivery 34

4.3 Vaccine Delivery to the Mucosal System and Skin 35

4.4 Intranasal Vaccine Delivery 35

4.5 Oral Vaccine Delivery 37

4.6 Transdermal Vaccine Delivery 39

4.6.1 Intercell 39

4.6.2 Microneedles for Intradermal Delivery 40

4.7 Conclusions 40

5 Diabetes 41

5.1 Introduction 41

5.2 Innovation in Insulin Delivery 41

5.2.1 Inhaled Insulin 41

5.2.2 Oral Insulin 43

5.2.3 Buccal Insulin 44

5.2.4 Transdermal Insulin 45

5.3 Next Generation Insulin Delivery Devices 45

5.3.1 Pens 45

5.3.2 Pumps 45

5.4 GLP-1 Analogues 46

5.5 Conclusions 48

6 Rheumatology 49

6.1 Introduction 49

6.2 Prefilled Syringes 50

6.3 Autoinjectors 50

6.3.1 New Materials in Autoinjector Design 52

6.4 Alternatives to Autoinjectors 53

6.4.1 Jet Injectors 53

6.4.2 Other Needle-Free Devices 54

6.4.3 Novel Injectors 55

6.5 Conclusions 55

7 Respiratory Diseases 57

7.1 Introduction 57

7.2 Drug Delivery Devices 57

7.2.1 Pressurized Metered Dose Inhalers 57

7.2.2 Dry Powder Inhalers 58

7.2.3 Aerosol Delivery Methods 58

7.2.4 Advances in Particle Engineering 60

7.2.5 Introduction of Electronics 61

7.3 Innovation in Drug Carriers for Pulmonary Drug Delivery 61

7.4 Alternative Routes of Delivery 61

7.5 Conclusions 62

8 Outlook 63

9 Appendix 65

9.1 Abbreviations 65

9.2 References 66

9.3 Methodology 68

9.3.1 Primary Research 68

9.3.2 Secondary Research 68

9.4 Contact Us 69

9.5 Disclaimer 69

 

List of Tables

 

1.1 List of Tables

Table 1: Innovation in Drug Delivery, Blockbuster Products Including Drug Delivery Systems, 2012 11

Table 2: Innovation in Drug Delivery, Examples of Leading Drug Delivery Companies, 2012 15

Table 3: Innovation in Drug Delivery, Examples of Licensing Deals for Drug Delivery, 2012 17

Table 4: Innovation in Drug Delivery, Examples of Licensing Deals for Drug Delivery, 2012 18

Table 5: Innovation in Drug Delivery, Examples of Oncology Drugs in Clinical Development with Drug Delivery Systems (by Technology Platform), 2012 21

Table 6: Innovation in Drug Delivery, Advances in PEGylation Technologies, 2012 23

Table 7: Innovation in Drug Delivery, Examples of Nanoparticulate Drug Delivery Systems, 2012 26

Table 8: Innovation in Drug Delivery, Approved Cancer Drugs with Liposomal Delivery Systems, 2012 26

Table 9: Innovation in Drug Delivery, Companies Developing Viral Vector Delivery Systems for Vaccines, 2012 33

Table 10: Innovation in Drug Delivery, Companies Developing Intranasal Vaccines and their Technologies, 2012 36

Table 11: Innovation in Drug Delivery, Companies Developing Oral Vaccines and their Technologies, 2012 38

Table 12: Innovation in Drug Delivery, Companies Developing Transdermal Vaccines and their Technologies, 2012 39

Table 13: Innovation in Drug Delivery, Inhaled Insulin Products and their Development Status, 2012 42

Table 14: Innovation in Drug Delivery, Oral Insulin Products and their Development Status, 2012 43

Table 15: Innovation in Drug Delivery, GLP-1 Analogs and their Development Status, 2012 47

Table 16: Innovation in Drug Delivery, Leading Drugs for Arthritis and their Delivery Systems, 2012 49

Table 17: Innovation in Drug Delivery, Leading Autoinjector Manufacturers and their Products, 2012 51

Table 18: Innovation in Drug Delivery, Examples of Liquid Jet Injectors for Needle Free Delivery, 2012 53

Table 19: Innovation in Drug Delivery, Companies Commercializing Aerosol Drug Delivery Technologies, 2012 59

Table 20: Innovation in Drug Delivery, Drug Delivery Requirements in Different Therapeutic Areas, 2012 63

 

List of Figures

 

1.2 List of Figures

Figure 1: Innovation in Drug Delivery, Commonly Used Options for Drug Delivery, 2012 8

Figure 2: Innovation in Drug Delivery, Uses of Drug Delivery Technology, 2012 9

Figure 3: Innovation in Drug Delivery, Commercial Opportunities for Drug Delivery Systems, 2012 10

Figure 4: Innovation in Drug Delivery, Reducing Drug Toxicity Through Drug Delivery, 2012 20

 

Companies Mentioned

 

N/A

 

 

 

To order this report:

Drug_Delivery_Technology Industry: Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance

 

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

 


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend
2. Siemens Unveils New Solutions and Latest Innovations at AACC 2012
3. Young Innovations, Inc. Provides 2nd Quarter Conference Call Details
4. Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations, Regulatory Approvals and Increasing Disease Prevalence Present Growth Opportunities
5. Innovations for Osteoarthritis, Sports Injuries and Orthopedic Practices
6. NFLPA and THERAPEARL, LLC Partner to Provide Athletes with Game Changing Innovations in Hot and Cold Pack Therapy
7. Drug Discovery Technologies Market Soars to $79 billion by 2017, Driven by Innovations in Pipeline and Tools Development
8. Freedom Innovations Wins the American Technology Award for Health & Medical Technologies
9. Philips demonstrates innovations in nuclear medicine imaging with a comprehensive portfolio of NM applications for IntelliSpace Portal
10. Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
11. Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):